FDA Approves Natalizumab For Sandoz And Polpharma Biologics

Tyruko Biosimilar Rival To Tysabri Approved In US Following Recent European Nod

 
• By Dave Wallace
  
US flag thumbs up
Tyruko has now been approved in the US • Source: Shutterstock

More from Products

More from Generics Bulletin